# Vistagen Therapeutics, Inc.: Form DEF 14A, filed Jul 28, 2025

- Company: [Vistagen Therapeutics, Inc.](/companies/vtgn.md) (CIK 1411685)
- Form: DEF 14A
- Filed: 2025-07-28
- Accepted by EDGAR: Jul 28, 2025, 17:14 ET
- Period: 2025-09-09
- Accession: 0001411685-25-000052
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1411685/000141168525000052/vtgn-20250728.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1411685/000141168525000052/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1411685/000141168525000052/vtgn-20250728.htm

Filed Jul 28, 2025.
Source: SEC EDGAR, the filing index for accession 0001411685-25-000052. Last ingested by Listed: Nov 14, 2026, 19:41 ET. No prices; not investment advice.
